Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125038472 | 12503847 | 2 | F | 20140720 | 20160629 | 20160628 | 20160707 | EXP | FR-PFIZER INC-2016316446 | PFIZER | 69.00 | YR | M | Y | 0.00000 | 20160707 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125038472 | 12503847 | 1 | PS | Triatec | RAMIPRIL | 1 | Oral | 1 DF, DAILY | Y | 19901 | 1 | DF | TABLET | ||||||
| 125038472 | 12503847 | 2 | SS | Triatec | RAMIPRIL | 1 | Oral | 1 DF, DAILY | Y | 19901 | 1 | DF | TABLET | ||||||
| 125038472 | 12503847 | 3 | SS | LASILIX | FUROSEMIDE | 1 | Oral | 2 DF, DAILY | Y | 0 | 2 | DF | |||||||
| 125038472 | 12503847 | 4 | SS | LASILIX | FUROSEMIDE | 1 | Oral | 2 DF, DAILY | Y | 0 | 2 | DF | |||||||
| 125038472 | 12503847 | 5 | SS | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | 1 DF, DAILY | Y | 0 | 1 | DF | |||||||
| 125038472 | 12503847 | 6 | SS | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | 1 DF, DAILY | Y | 0 | 1 | DF | |||||||
| 125038472 | 12503847 | 7 | C | CARDENSIEL | BISOPROLOL FUMARATE | 1 | UNK | 0 | |||||||||||
| 125038472 | 12503847 | 8 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 125038472 | 12503847 | 9 | C | LYRICA | PREGABALIN | 1 | UNK | 0 | |||||||||||
| 125038472 | 12503847 | 10 | C | INEXIUM | ESOMEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 125038472 | 12503847 | 11 | C | TOPALGIC LP | TRAMADOL | 1 | UNK | 0 | |||||||||||
| 125038472 | 12503847 | 12 | C | KARDEGIC | ASPIRIN LYSINE | 1 | UNK | 0 | |||||||||||
| 125038472 | 12503847 | 13 | SS | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125038472 | 12503847 | OT |
| 125038472 | 12503847 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125038472 | 12503847 | Acute kidney injury | |
| 125038472 | 12503847 | Blood pressure decreased | |
| 125038472 | 12503847 | Erysipelas | |
| 125038472 | 12503847 | Fall | |
| 125038472 | 12503847 | Hyperkalaemia | |
| 125038472 | 12503847 | Ulna fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125038472 | 12503847 | 1 | 20140720 | 0 | ||
| 125038472 | 12503847 | 2 | 20140722 | 20140804 | 0 | |
| 125038472 | 12503847 | 3 | 20140720 | 20140720 | 0 | |
| 125038472 | 12503847 | 4 | 20140722 | 20140804 | 0 | |
| 125038472 | 12503847 | 5 | 20140720 | 20140720 | 0 | |
| 125038472 | 12503847 | 6 | 20140722 | 20140804 | 0 |